D. E. Shaw & Co., Inc. European Biotech Acquisition Corp. Transaction History

D. E. Shaw & Co., Inc.

$107 Billion
Q3 2024

Shares

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$9.94 - $10.1 $1.49 Million - $1.52 Million	150,000 Added 58.01%	408,574 $4.13 Million
Q3 2022 Nov 14, 2022	BUY	$9.8 - $10.02 $3,920 - $4,008	400 Added 0.15%	258,574 $2.57 Million
Q1 2022 May 16, 2022	SELL	$9.69 - $9.8 $1.32 Million - $1.33 Million	-135,985 Reduced 34.5%	258,174 $2.52 Million
Q4 2021 Feb 14, 2022	BUY	$9.67 - $9.83 $1.6 Million - $1.62 Million	165,129 Added 72.1%	394,159 $3.82 Million
Q3 2021 Nov 15, 2021	BUY	$9.62 - $9.74 $1.88 Million - $1.91 Million	195,697 Added 587.1%	229,030 $2.22 Million
Q2 2021 Aug 16, 2021	BUY	$9.69 - $10.29 $322,996 - $342,996	33,333 New	33,333 $322,000

Others Institutions Holding EBAC

# of Institutions

1

Shares Held

0

Call Options Held

0

Put Options Held

0

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

About European Biotech Acquisition Corp.

Ticker EBAC
Exchange NASDAQ
Sector Financial Services
Industry Shell Companies
Shares Outstandng 13,209,900

More about EBAC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.